A bespoke CRISPR base-editing therapy created for infant KJ Muldoon marks a shift toward personalized gene treatments ...

Beam Therapeutics is reaffirmed as a long-term buy, with significant upside expected around 2028–2029 as BEAM-302 advances.

Has America lost its monopoly on cool? The Opinion culture editor Nadja Spiegelman joins the American expats and authors W.

Experts at the company don't know what the newfound system does, so its potential utility in biology—if any—remains unclear.

Microbial cell factories that produce pharmaceutical ingredients and other useful compounds include both the bacterium ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Gears of War: E-Day is the rare modern game that features a local co-op campaign. The Coalition devs tell Polygon it was ...

Watch Big Brother 28 runner-up Taylor Brown's exit interview with TVLine Staff Editor Nick Caruso, where Taylor opens up about convincing Rick Devens to take her to the end, reveals whether she would ...

Gypsy Rose Blanchard’s fiancé, Ken Urker, died at his Louisiana home on Thursday, which was his 34th birthday. A family member found him unresponsive, a source close to the family told People. The ...

A research team led by Lawrence Berkeley National Laboratory (Berkeley Lab) has developed a new imaging technique that could ...

Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos ...

AI has cracked a secret code from Napoleon Bonaparte. His stepson, Eugene, the Viceroy of Italy, sent a letter to General ...